PRGO FY 2022 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.5B+7.6% YoY

Gross Profit

$1.5B32.7% margin

Operating Income

$79M1.8% margin

Net Income

-$141M-3.2% margin

EPS (Diluted)

$-0.97

Cash Flow

Operating Cash Flow

$307M

Free Cash Flow

$211M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$6.2B

Stockholders' Equity

$4.8B

Cash & Equivalents

$601M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.5B	$4.1B	+7.6%
Gross Profit	$1.5B	$1.4B	+2.8%
Operating Income	$79M	$410M	-80.8%
Net Income	-$141M	-$69M	-104.1%